CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-A12B/A Other Registration Statement
- PRER14A Other PRER14A
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- DEL AM Other DEL AM
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- CT ORDER Other Confidential Order
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
Page 2 of 9 · 166 filings